Part of clients' anxiety about this issue stems from the uncertainty of how much or how long such health care expenses will be incurred.

President Donald Trump, who made affordability a centerpiece of his inaugural speech on Monday, is expected to cut costs ...

Guardant Health has secured Medicare coverage from Palmetto for its blood test to monitor for disease recurrence in patients with colorectal cancer.

The General Enrollment Period provides an opportunity to make up for a past oversight – the failure to enroll in Part B.

An advocacy group aligned with Democrats will launch a $10 million “Hands Off Medicaid” campaign that highlights how the ...

The rescinded order directed Medicare and Medicaid to test ways to lower drug costs for enrollees. Those tests hadn’t started ...

Trump’s executive order halts an effort to cap the copayment for generic medications at $2 for Medicare beneficiaries.

NEW YORK – Guardant Health announced Tuesday that its Guardant Reveal liquid biopsy test has received coverage from Medicare administrative contractor Palmetto GBA to monitor colorectal cancer ...

Older Australians, particularly retirees or those on lower incomes, were more likely to select hospital insurance based on ...

Hospitals are also seeing higher uncompensated care as individuals lose Medicaid coverage or decide not to purchase health insurance. If there are changes to the health insurance exchanges, more ...

The test was previously covered for use in colorectal cancer patients in the early post-surgical setting only.

If successful, the result could be lower Medicare Part D prices for drugs used to create a variety of conditions, such as ...